CHA Bio Group｜차바이오그룹 Revenue

Biotechnology Research • 335, pangyo-ro, Korea, Republic of • 51-100 Employees

CHA Bio Group｜차바이오그룹 revenue & valuation

Annual revenue	$5,047,745
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$16,200,000
Total funding	No funding

Key Contact at CHA Bio Group｜차바이오그룹

Donggoo Bae

Senior Managing Director

Company overview

Headquarters	335, pangyo-ro, CHA Bio Complex, Bundang-gu, Seongnam-si, Gyeonggi-do 13488, KR
Website	chabio.com
NAICS	541714
Keywords	VC, CRO, Cosmetics, Pharmaceuticals, BT, Stem Cell, Cdmo, Digital Healthcare, Vaccine, CGT, Medical Healthcare, Nk Cell
Employees	51-100

CHA Bio Group｜차바이오그룹 Email Formats

CHA Bio Group｜차바이오그룹 uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 48.2% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	48.2%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	24.1%
{first name}@company.com	john@company.com	12.4%
{last name}.{first name}@company.com	doe.john@company.com	8.9%
{first name}{last name}@company.com	johndoe@company.com	6.4%

About CHA Bio Group｜차바이오그룹

차바이오그룹은 바이오∙헬스케어 산업에서 최초을 넘어 최고를 향한 도전을 이어가고 있습니다. 국내 유일의 산∙학∙연∙병(産∙學∙硏∙病) 에코시스템과 세계 최대 셀라이브러리, 면역증강플랫폼 등 차별화된 R&D 역량으로 세포∙유전자치료제, 차세대 백신, 표적항암제 등 첨단 바이오의약품을 개발하고 있습니다. 차바이오그룹은 차바이오텍, CMG제약, 차백신연구소 3개의 상장기업과 차헬스케어, 차메디텍, 차바이오F&C, 차케어스, 서울CRO, 솔리더스인베스트먼트 등의 기업들이 수직 계열화를 통해 비즈니스를 극대화하고 있습니다. 차바이오그룹의 도전과 혁신은 계속됩니다. 미국 마티카 바이오테크놀로지를 통해 3세대 CGT CDMO 사업을 본격화하고 있으며, LA 할리우드 차병원을 시작으로 미국, 호주, 일본, 동남아시아에 직접 진출해 메디컬 한류를 선도하고 있습니다. CHA Bio Group is continuing its challenge to become the best in various initial achievements in the bio and healthcare fields. We are developing and producing advanced biopharmaceuticals, including cell and gene therapy products and vaccines, based on our global R&D capabilities, such as our unique ‘CHA Bio ecosystem’: Academic, Research, Medical Network, and Bio-Industry Business, the world's largest cell library, and our independently developed vaccine adjuvant platform. We will leap forward as a true global bio company centered on the third-generation CGT CDMO and global healthcare business.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

CHA Bio Group｜차바이오그룹 has 13 employees across 10 departments.

Departments

Number of employees

Funding Data

CHA Bio Group｜차바이오그룹 has never raised funding before.

CHA Bio Group｜차바이오그룹 Tech Stack

Discover the technologies and tools that power CHA Bio Group｜차바이오그룹's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

jQuery

JavaScript libraries

Windows Server

Operating systems

Slick

JavaScript libraries

Open Graph

Miscellaneous

GSAP

JavaScript frameworks

IIS

Web servers

Swiper

JavaScript libraries

Microsoft ASP.NET

Web frameworks

jQuery UI

JavaScript libraries

cdnjs

CDN

Frequently asked questions

CHA Bio Group｜차바이오그룹 is located in 335, pangyo-ro, KR.

CHA Bio Group｜차바이오그룹 generates an estimated annual revenue of $5,047,745. This revenue figure reflects the company's market position and business performance in its industry.

CHA Bio Group｜차바이오그룹 has an estimated valuation of $16,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

CHA Bio Group｜차바이오그룹 has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at CHA Bio Group｜차바이오그룹

Donggoo Bae

Senior Managing Director

4.8

40,000 users